Insiders · Profile

Christianson Mark

Market Development Director at NEUROONE MEDICAL TECHNOLOGIES. Filing since 12 Jun 2020. CIK 0001709738

Company
Date
Role
Action
Shares
Amount
Of holding
30 Jun 2026
Market Development Director
Sold at will
10,000
$31.77K
32.6%
30 Mar 2026
Business Development Director
Sold at will
15,363
$11.37K
7.2%
13 Mar 2026
Business Development Director
Sold at will
100
$80.00
0.0%
12 Mar 2026
Business Development Director
Sold at will
817
$653.60
0.4%
11 Mar 2026
Business Development Director
Sold at will
2,109
$1.69K
1.0%
10 Mar 2026
Business Development Director
Sold at will
11,611
$9.29K
5.1%
5 Sep 2025
Business Development Director
Sold at will
30,000
$22.20K
11.5%
4 Jun 2025
Business Development Director
Sold at will
10,000
$5.80K
3.7%
22 May 2025
Business Development Director
Sold at will
8,967
$5.59K
3.2%
21 May 2025
Business Development Director
Sold at will
14
$9.10
0.0%
20 May 2025
Business Development Director
Sold at will
3,013
$1.98K
1.1%
19 May 2025
Business Development Director
Sold at will
8,006
$5.33K
2.7%
6 Jun 2024
Business Development Director
Sold at will
2,189
$1.92K
0.7%
5 Jun 2024
Business Development Director
Sold at will
25,800
$22.66K
8.0%
27 Dec 2023
Business Development Director
Sold at will
31,445
$45.86K
9.5%
26 Dec 2023
Business Development Director
Sold at will
6,848
$9.27K
2.0%
22 Dec 2023
Business Development Director
Sold at will
1,800
$2.52K
0.5%
21 Dec 2023
Business Development Director
Sold at will
9,907
$13.87K
2.8%
23 Mar 2023
Business Development Director
Sold at will
12,711
$19.09K
3.6%
22 Mar 2023
Business Development Director
Sold at will
11,667
$17.60K
3.2%
21 Mar 2023
Business Development Director
Sold at will
2,122
$3.41K
0.6%
24 Jun 2021
Business Development Director
Sold, plan not stated
600
$3.78K
0.1%
23 Jun 2021
Business Development Director
Sold, plan not stated
11,300
$76.20K
1.0%
12 Jun 2020
VP of Market Development
Sold, plan not stated
334,000
$200.40K
23.5%
24 decisions on file.